Showing results (41-50 of 345) with videos related to

Sort By:
Pageof 35
Journal of the American College of Cardiology|December 13, 2006
Protective effects of erythropoietin in cardiac ischemia: from bench to bedsideErik Lipsic, Regien G Schoemaker, Peter van der Meer, et al.
Chemical Communications (Cambridge, England)|April 29, 2020
Red-light-sensitive BODIPY photoprotecting groups for amines and their biological application in controlling heart rhythmKaja Sitkowska, Martijn F Hoes, Michael M Lerch, et al.
European Journal of Heart Failure|December 23, 2009
Red blood cell distribution width and 1-year mortality in acute heart failureRoland R J van Kimmenade, Asim A Mohammed, Shanmugam Uthamalingam, et al.
Journal of the American College of Cardiology|July 6, 2004
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failurePeter van der Meer, Adriaan A Voors, Erik Lipsic, et al.
Stem Cell Reports|November 29, 2013
Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytesAdam W Feinberg, Crystal M Ripplinger, Peter van der Meer, et al.
Circulation|January 6, 2010
Endogenous erythropoietin and outcome in heart failureAnne M S Belonje, Adriaan A Voors, Peter van der Meer, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 17, 2015
[Parenteral iron therapy in chronic kidney disease or chronic heart failure]Michele F Eisenga, Adry Diepenbroek, Dorine W Swinkels, et al.
Nature Reviews. Cardiology|September 14, 2023
Immunomodulation and immunopharmacology in heart failureGeorge Markousis-Mavrogenis, Lukas Baumhove, Ali A Al-Mubarak, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2017
Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizationsEline L Vegter, Ekaterina S Ovchinnikova, Dirk J van Veldhuisen, et al.
Pageof 35